These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
    Author: Blauw GJ, van Brummelen P, Bruning T, van Zwieten PA.
    Journal: J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S41-3. PubMed ID: 2459513.
    Abstract:
    The vascular effects of serotonin and the selective 5-HT2 antagonist ketanserin were investigated in the forearm of healthy subjects. The drugs were infused into the brachial artery in doses that did not elicit systemic hemodynamic effects (0.1-80 ng/kg/min for serotonin and 5-125 ng/kg/min for ketanserin). The interaction between serotonin and ketanserin was studied by combined infusions of serotonin with ketanserin, and the relative 5-HT2 and alpha 1-adrenoceptor blocking potencies of ketanserin were studied by simultaneous infusions of the selective alpha 1-agonist methoxamine, the indirect sympathomimetic drug tyramine, and serotonin with two doses of ketanserin. Forearm blood flow (FBF) was measured by venous occlusion plethysmography. Heart rate and intra-arterial blood pressure were recorded continuously. All doses of serotonin induced an initial transient vasodilation that was followed by a steady vasodilation for the lower doses (0.1-10 ng/kg/min) and a steady vasoconstriction for the highest dose of serotonin (p less than 0.05). Ketanserin induced a dose-dependent vasodilation, which was significant from the dose of 15 ng/kg/min (p less than 0.05). The vasodilation induced by serotonin (1 ng/kg/min) was significantly enhanced by ketanserin, whereas the vasoconstriction elicited by serotonin of 80 ng/kg/min was reversed by ketanserin (p less than 0.05). The vasoconstriction induced by methoxamine and tyramine was attenuated at a lower dose of ketanserin than the vascular response induced by serotonin. It is concluded that serotonin acts mainly as a vasodilatator in healthy subjects, whereas only at very high doses is vasoconstriction mediated by 5-HT2 receptors observed. The vasodilation induced by ketanserin is most likely due to its alpha 1-adrenoceptor blocking potencies.
    [Abstract] [Full Text] [Related] [New Search]